Section 459.1. Uniform Statewide preferred drug list.--(a) The department may not implement a uniform Statewide preferred drug list for the medical assistance managed care organizations until an analysis has been conducted, as commissioned by the department, to determine the projected cost to the medical assistance managed care organization and the projected supplemental rebates that could be obtained by the department through the use of a uniform Statewide preferred drug list.
(b) The analysis under subsection (a) shall be completed within sixty days of the effective date of this subsection. The analysis shall be delivered to the following:
(1) The chairperson and minority chairperson of the Appropriations Committee of the Senate.
(2) The chairperson and minority chairperson of the Appropriations Committee of the House of Representatives.
(3) The chairperson and minority chairperson of the Health and Human Services Committee of the Senate.
(4) The chairperson and minority chairperson of the Health Committee of the House of Representatives.
(459.1 added June 28, 2019, P.L.168, No.19)